Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Leroy

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
Epidemiology and Infection|August 1, 2019
Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP studyT Semenova, B Nemoz, V Thibault, et al.
The Journal of Urology|December 18, 2007
Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized studyG Roussey-Kesler, V Gadjos, N Idres, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 12, 2021
Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled TrialsJoely Kaufman-Janette, John H Joseph, Michael S Kaminer, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferonJ P Zarski, M Maynard-Muet, S Chousterman, et al.
Revue D'Epidemiologie Et De Sante Publique|June 25, 2022
[Sexual and reproductive health of adolescents living with HIV in pediatric care programs in Abidjan : Structured provision of care and perceptions of health care workers in 2019]M H Dassi Tchoupa Revegue, J Jesson, H Aka Dago-Akribi, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2018
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT studyR Anty, G Favre, A Coilly, et al.
Annales De Dermatologie Et De Venereologie|May 21, 2025
French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and childrenS Ingen-Housz-Oro, C Bernier, H Assier, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Epidemiology and Infection|August 1, 2019
Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP studyT Semenova, B Nemoz, V Thibault, et al.
The Journal of Urology|December 18, 2007
Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized studyG Roussey-Kesler, V Gadjos, N Idres, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 12, 2021
Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled TrialsJoely Kaufman-Janette, John H Joseph, Michael S Kaminer, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferonJ P Zarski, M Maynard-Muet, S Chousterman, et al.
Revue D'Epidemiologie Et De Sante Publique|June 25, 2022
[Sexual and reproductive health of adolescents living with HIV in pediatric care programs in Abidjan : Structured provision of care and perceptions of health care workers in 2019]M H Dassi Tchoupa Revegue, J Jesson, H Aka Dago-Akribi, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2018
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT studyR Anty, G Favre, A Coilly, et al.
Annales De Dermatologie Et De Venereologie|May 21, 2025
French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and childrenS Ingen-Housz-Oro, C Bernier, H Assier, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Pageof 20